Ripretinib intra-patient dose escalation (IPDE) following disease progression provides clinically meaningful progression-free survival (PFS) in gastrointestinal stromal tumor (GIST) in phase I Meeting Abstract
| Authors: | Janku, F.; Chi, P.; Heinrich, M.; von Mehren, M.; Jones, R. L.; Ganjoo, K.; Trent, J.; Gelderblom, H.; Abdul Razak, A.; Gordon, M.; Somaiah, N.; Jennings, J.; Shi, K.; Ruiz-Soto, R.; George, S. |
| Abstract Title: | Ripretinib intra-patient dose escalation (IPDE) following disease progression provides clinically meaningful progression-free survival (PFS) in gastrointestinal stromal tumor (GIST) in phase I |
| Meeting Title: | ESMO Virtual Congress 2020 |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Sep 19-21/Oct 16-18 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-09-01 |
| Start Page: | S974 |
| End Page: | S975 |
| Language: | English |
| ACCESSION: | WOS:000573469102210 |
| DOI: | 10.1016/j.annonc.2020.08.1849 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1623MO -- Source: Wos |
